| Title | Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy. |
| Publication Type | Journal Article |
| Year of Publication | 2020 |
| Authors | Ramakrishna R, Diamond TH, Alexander W, Manoharan A, Golombick T |
| Journal | Clin Case Rep |
| Volume | 8 |
| Issue | 4 |
| Pagination | 739-744 |
| Date Published | 2020 Apr |
| ISSN | 2050-0904 |
| Abstract | Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor. |
| DOI | 10.1002/ccr3.2735 |
| Alternate Journal | Clin Case Rep |
| PubMed ID | 32274049 |
| PubMed Central ID | PMC7141712 |